Johnson & Johnson is the fourth experimental COVID-19 shot to enter the final stage of testing in the U.S. after starting a 60,000-person clinical trial, the company said Wednesday.
More
Today: July 28, 2026
Johnson & Johnson is the fourth experimental COVID-19 shot to enter the final stage of testing in the U.S. after starting a 60,000-person clinical trial, the company said Wednesday.
More